Quick Summary
Elective surgery waiting times across the UK, Germany, Sweden, and Norway now regularly exceed 12–24 months for common procedures. European patients have a legal right to seek treatment privately — including abroad. China's Grade 3A hospitals offer the same procedures with no waiting list, at 50–70% below European private rates.
- →UK (NHS): median wait for elective treatment now over 14 weeks; 1 in 8 patients waiting over 52 weeks as of early 2026
- →Germany (GKV): statutory insured patients wait 3–5× longer than privately insured for specialist appointments; orthopaedic waits of 6–18 months common
- →Sweden: average wait for hip replacement 6–12 months; healthcare guarantee (vårdgarantin) regularly breached
- →Norway: 70% of patients wait more than 3 months for elective surgery; some orthopaedic waits exceed 24 months
- →All European residents have the right to seek private treatment abroad — your public health entitlement is not affected
Waiting time data in this article draws on publicly available national health statistics current as of early 2026. Figures vary by region, specialty, and hospital. This article is for informational purposes only and does not constitute medical advice.
Why Waiting Times Matter Clinically — Not Just Practically
A waiting list is not a neutral inconvenience. For hip and knee replacement, patients waiting over 12 months show measurable decline in functional mobility, mental health outcomes, and surgical complexity at the time of operation. For cancer diagnoses, delays of weeks — not months — affect survival rates for fast-growing tumours. For IVF patients, each year of delay has a direct impact on success rates correlated with age. The decision to explore alternatives is not impatience. For many patients, it is a medically rational response to a system under structural strain.
United Kingdom: NHS Waiting Lists
The NHS waiting list for elective care in England reached a record 7.6 million in 2024 and remains above 7 million as of early 2026. The median wait across all specialties is now over 14 weeks. One in eight patients on the elective waiting list has been waiting over 52 weeks.
| Procedure | Typical NHS wait (2025–2026) | Notes |
|---|---|---|
| Hip replacement | 12–24 months | Varies significantly by NHS trust and region |
| Knee replacement | 12–24 months | Longest waits in orthopaedics nationally |
| Cataract surgery | 6–18 months | High volume backlog post-pandemic |
| IVF (NHS-funded cycles) | 12–24 months | Eligibility criteria vary by ICB; many patients not eligible |
| Cancer treatment (urgent) | 2-week rule for referral; then further waits | 62-day target from referral to treatment frequently missed |
| Spinal surgery | 18–36 months | One of the longest-wait specialties |
Your rights as an NHS patient
Under the NHS Constitution, patients have the right to start consultant-led treatment within 18 weeks of referral. This target is currently being missed for a significant proportion of patients. You also have the legal right to seek treatment at another NHS provider, go private in the UK, or seek private treatment abroad. Exercising these rights does not remove you from the NHS waiting list unless you explicitly withdraw.
Germany: Two-Tier Waiting Times Under GKV
Germany's statutory health insurance system (GKV — Gesetzliche Krankenversicherung) covers approximately 90% of the population. Privately insured patients (PKV) receive faster specialist access under the same system — a structural two-tier dynamic that has been formally documented by the Bundesärztekammer (German Medical Association).
| Procedure / appointment type | GKV wait (statutory) | PKV wait (private) | Notes |
|---|---|---|---|
| Specialist outpatient appointment | 3–6 weeks | 4–6 days | Documented 3–5× differential (KBV data) |
| Hip replacement | 6–18 months | 2–6 weeks | Regional variation; longer in rural areas |
| Knee replacement | 6–18 months | 2–6 weeks | Among the most common elective procedures |
| IVF (GKV-funded) | 3–6 months | Faster | GKV funds 50% of up to 3 cycles for eligible married couples |
| Spinal surgery | 12–24 months | 4–12 weeks | Particularly long waits in non-university hospitals |
GKV patients: what the reform discussions mean in practice
Political discussion about the GKV/PKV two-tier system continues but structural reform has not materialised. GKV patients in 2026 face the same access differential they faced in 2020. The Terminservicestellen (appointment service centres) introduced to improve access have reduced acute waits in some specialties but have not addressed the elective surgery backlog. Patients with mobility-limiting conditions who are told to wait 12–18 months for an orthopaedic assessment — let alone surgery — face a clinically significant delay.
Sweden: Vårdgarantin and the Gap Between Policy and Reality
Sweden's healthcare guarantee (vårdgarantin) commits to: contact with primary care the same day, a primary care appointment within 3 days, specialist referral assessment within 7 days, and specialist treatment beginning within 90 days of referral. In practice, the 90-day treatment guarantee is regularly missed — particularly for orthopaedics, urology, and ophthalmology.
| Procedure | Typical wait (2025–2026) | Vårdgarantin target | Status |
|---|---|---|---|
| Hip replacement | 6–14 months | 90 days | Target regularly missed |
| Knee replacement | 6–14 months | 90 days | Target regularly missed |
| Cataract surgery | 4–10 months | 90 days | Significant regional variation |
| IVF (landsting-funded) | 6–18 months | No national guarantee | Varies by region (landsting) |
| Spine/back surgery | 12–24 months | 90 days | Among longest waits nationally |
The regional variation problem
Sweden's healthcare is administered by 21 regions (regioner), and waiting times vary considerably between them. A patient in Stockholm may wait 6 months for hip replacement while a patient in a rural region waits 14 months for the same procedure. The Swedish Agency for Health and Care Services Analysis (Vård- och omsorgsanalys) has repeatedly documented this disparity. Patients do have the right to seek care in another region (patientlagen 2014:821), but this right is underused and does not address the core capacity constraint.
Norway: Helfo and the Fritt Behandlingsvalg System
Norway's public health system (covered by Helfo under the Norwegian Health Economics Administration) provides strong coverage but faces significant elective waiting pressures. The fritt behandlingsvalg (free choice of treatment) reform allows patients to choose private providers at public expense in some cases — but capacity constraints mean this does not eliminate waits.
| Procedure | Typical wait (2025–2026) | Notes |
|---|---|---|
| Hip replacement | 9–20 months | Varies by health trust (helseforetak) |
| Knee replacement | 9–20 months | Among the most backlogged procedures nationally |
| Cataract surgery | 4–12 months | Significant regional variation |
| IVF (public-funded) | 6–18 months | Public funding limited; many patients self-fund |
| Spinal surgery | 12–30 months | Longest-wait specialty in many regions |
What Norwegian patients can do within the system
Norwegian patients who exceed the maximum medically justified wait time (individuell frist) set by their specialist have the right to seek care at an approved private provider, with Helfo funding. In practice, this right requires the patient to proactively request re-referral and navigate an administrative process. For many patients, the practical barrier is high. Those with resources to self-fund — or to seek treatment abroad — face a more direct route.
Your Options When You Cannot Wait
European patients facing long elective waiting lists have three main categories of alternative:
1. Private treatment in your home country
Fastest to arrange, no travel required. Costs for common elective procedures in UK, German, Swedish, and Norwegian private hospitals are high — hip replacement in the UK typically costs £15,000–£25,000 privately; in Germany €15,000–€22,000. Availability depends on local private hospital capacity, which in some specialties is also constrained.
2. Treatment within the EU under EU cross-border directive
EU/EEA patients have the right under Directive 2011/24/EU to seek planned treatment in another EU member state and claim reimbursement from their home system — up to the amount your home system would have paid. In practice, reimbursement is capped at home-country tariffs (often far below private costs in the treating country), the administrative process is complex, and prior authorisation requirements apply for hospital care. For most patients, EU cross-border treatment is more useful in principle than in practice.
3. Private treatment abroad — including China
For patients who can travel, private treatment at an accredited hospital abroad offers no waiting list, costs 50–70% below European private rates, and no impact on home-country public health entitlements. China's Grade 3A hospitals in Beijing, Shanghai, Guangzhou, and other major cities offer the full range of elective procedures — orthopaedics, oncology, IVF, cardiac, dental — with English-speaking international patient departments and documented outcomes comparable to leading European centres.
Considering treatment in China?
Submit a free, confidential assessment and receive a personalised treatment roadmap within 24 hours — at no cost to you.
Get Your Free AssessmentCost Comparison: Waiting vs Going Abroad
For patients weighing the financial case, the relevant comparison is not home public system (free) vs abroad (full cost) — it is: how much does a long wait cost in mobility loss, pain, lost income, and quality of life, versus the all-in cost of treatment abroad? All-in China figures below include estimated return flights from Western Europe, 2–3 weeks' accommodation, and hospital fees. Individual quotes will vary — your treatment roadmap includes a specific all-in estimate before you commit.
| Procedure | UK private (£) | Germany private (€) | China (€) | All-in China incl. travel (est.) |
|---|---|---|---|---|
| Hip replacement | £15,000–£25,000 | €15,000–€22,000 | €5,000–€9,000 | €8,000–€13,000 |
| Knee replacement | £13,000–£22,000 | €13,000–€20,000 | €5,000–€8,500 | €8,000–€12,500 |
| Cataract (per eye) | £2,000–£3,000 | €2,000–€3,500 | €600–€1,200 | €2,000–€3,500 (both eyes) |
| IVF (1 cycle) | £4,000–£6,000 | €3,500–€6,000 | €2,500–€4,500 | €4,500–€7,000 |
| Spinal surgery | £12,000–£30,000 | €12,000–€28,000 | €6,000–€15,000 | €9,000–€18,000 |
Does Seeking Treatment Abroad Affect Your Home Country Coverage?
No. Seeking private treatment abroad — including in China — does not affect your NHS registration, GKV entitlement, Swedish region coverage, or Norwegian Helfo coverage. You retain full access to your home system before and after treatment. Your GP or home specialist manages post-operative follow-up using the English discharge documentation you bring back from your Chinese hospital.
- UK: NHS GPs cannot remove you from their list or refuse follow-up care because you sought treatment abroad
- Germany: GKV entitlement is contribution-based and independent of where you receive elective treatment
- Sweden: patientlagen rights and healthcare guarantee entitlement are unaffected by private treatment abroad
- Norway: Helfo coverage continues regardless of where you seek private elective care
Frequently Asked Questions
How long is the NHS waiting list for hip replacement in 2026?
Most NHS patients wait 12–24 months for hip replacement, depending on the trust and region. The NHS 18-week referral-to-treatment target is currently being missed for a significant proportion of orthopaedic patients. Some trusts have waits exceeding 24 months for hip and knee replacement.
How long do you wait for surgery in Sweden?
Sweden's healthcare guarantee (vårdgarantin) requires treatment to begin within 90 days of specialist referral. For elective orthopaedic procedures, this target is regularly missed. Typical waits for hip and knee replacement in Sweden are 6–14 months, with significant variation between regions. Spinal surgery waits can exceed 24 months.
How long is the waiting list for surgery in Germany?
For GKV (statutory) insured patients in Germany, waits for elective orthopaedic surgery typically range from 6–18 months. Specialist outpatient appointments take 3–6 weeks on average for GKV patients, versus 4–6 days for PKV (privately insured) patients. The two-tier access differential is well-documented and has not been resolved by reform efforts to date.
What are my options while waiting for NHS surgery?
You have several options: request a referral to a faster NHS trust under the NHS right to choose, seek private treatment in the UK (typically £13,000–£25,000 for major orthopaedic procedures), apply for an NHS-funded referral to a private provider via your ICB, or seek private treatment abroad. Treatment in China at a Grade 3A hospital costs 50–70% less than UK private rates, with no waiting list. Your NHS place is retained unless you explicitly withdraw.
Can I go to China while on a waiting list?
Yes. Being on an NHS or European public health waiting list does not prevent you from seeking private treatment abroad. You retain your place on the waiting list while you explore alternatives. If you proceed with treatment in China, you can inform your GP and they will continue to manage your follow-up care on return. Your public health entitlement is unaffected.
How long do Norwegian patients wait for surgery?
Norwegian patients typically wait 9–20 months for hip and knee replacement, depending on the health trust (helseforetak) and region. Around 70% of Norwegian patients wait more than 3 months for elective surgery. Spinal surgery waits can exceed 24–30 months in some regions. The fritt behandlingsvalg system allows some patients to access private providers at public expense, but the administrative process is complex.
Does going abroad for treatment affect my European health insurance?
No. Seeking private elective treatment abroad does not affect your NHS registration, German GKV entitlement, Swedish regional healthcare coverage, or Norwegian Helfo coverage. Your home system continues to cover you for all other healthcare needs before and after your treatment abroad. Post-operative follow-up is managed by your home GP using the English discharge documentation from your overseas hospital.
Is treatment in China cheaper than private treatment in Europe?
Yes, significantly. Hip replacement at a Grade 3A hospital in China costs €5,000–€9,000, versus £15,000–£25,000 privately in the UK or €15,000–€22,000 in Germany. Including flights and accommodation, the all-in cost for treatment in China is typically still 30–50% below European private rates for the procedure alone.
Related Guides
Ready to Explore Your Options?
Submit a free, confidential assessment. A coordinator will provide a personalised treatment plan within 24 hours.
Get Your Free Assessment